NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter
Go back to NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter| NEOGENOMICS (NASDAQ: NEO) | Delayed: 11.20 +0.07 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.13 | 52 Week High | $9.54 | |||
| Open | $11.11 | 52 Week Low | $5.49 | |||
| Day High | $11.34 | P/E | 280.00 | |||
| Day Low | $10.96 | EPS | $0.04 | |||
| Volume | 3,108,024 | |||||

